Despite these assumptions, our data suggest that an early DNA methylation event may commit the primary tumor to particular genomic trajectories, as suggested for MGMT hypermethylation preceding KRAS activating mutations in colorectal cancer37. This evidence concerns the gene KRAS and medical procedure.